StemoniX's microBrain® and microHeart® Platforms to be Featured in Podium Presentation at the PREDiCT: 4th Annual 3D Tissue Models Summit

StemoniX's Research and Development Director, Fabian Zanella, Ph.D., to present during the session "Physiologically-relevant 3D hiPSC-based platforms empowering drug discovery"

MAPLE GROVE, Minn., Sept. 3, 2019 — (PRNewswire) —   StemoniX, Inc, a biotech company revolutionizing how new therapeutics are discovered, announced today that its Research and Development Director, Fabian Zanella, Ph.D., will deliver a podium presentation, "Expertise Insight by StemoniX," highlighting the company's microBrain 3D and microHeart technology at the PREDiCT: 4th Annual 3D Tissue Models Summit in Boston, Sept. 4-6, 2019. The presentation will be featured as part of the "Physiologically-relevant 3D hiPSC-based platforms empowering drug discovery" session.

(PRNewsfoto/StemoniX)

During the podium presentation, Dr. Zanella will detail how 3D human induced pluripotent stem cell (hiPSC)-based platforms are being used to transform drug discovery and preclinical development. Case studies for StemoniX's advanced hiPSC-derived platforms will be presented, highlighting their ability to improve the outcomes of drug discovery and toxicity studies. He will focus on StemoniX's neural (microBrain) and cardiac (microHeart) platforms, in which human cells assemble to mimic native tissue composition promoting robust activity, as well as discuss the platforms' expected responses to known cellular modulators.

Ping Yeh, co-founder and CEO of StemoniX, said: "The PREDiCT: 4th Annual 3D Tissue Models Summit is an ideal event to showcase the potential of our technology to fundamentally alter and accelerate the development of therapeutics. As presented by Dr. Zanella, the StemoniX microBrain and microHeart platforms, engineered from human skin cells, enable high-throughput preclinical drug screening in a human system without the need for drugs to enter a human body. This capability, combined with StemoniX's scalable, high-volume manufacturing processes, offers the potential to deliver significant time and cost savings to the pharmaceutical industry while, at the same time, enhancing the safety, consistency, and accuracy of human clinical trials, which today rely on animal models and small human samples as predictors of drug interactions across an entire patient population."

Podium Presentation Details

Title:


Expertise Insight by StemoniX

Session:


Physiologically-relevant 3D hiPSC-based platforms empowering drug
discovery

Event


PREDiCT: 4th Annual 3D Tissue Models Summit

Date:


Sept. 5, 2019

Time:


10 a.m. – 10:30 a.m., EDT

Location:


Boston, MA

About StemoniX
StemoniX is empowering the discovery of new medicines to treat challenging diseases via the world's first ready-to-use assay plates containing living human microOrgans®, including electrophysiologically active neural (microBrain®) and cardiac (microHeart®) cells. Predictive, accurate, and consistent, StemoniX's products enable pharmaceutical scientists to quickly and economically conduct high-throughput screening in a simplified workflow. Through their Discovery as a Service branch, the company also partners with organizations to screen compounds as well as create customized microOrgan models and assays tailored to individual discovery and toxicity needs. Visit StemoniX.com to learn how StemoniX is helping global institutions humanize drug discovery and development to bring the most promising medicines to patients.

Tiberend Strategic Advisors, Inc.

Investor Contact:
Tirth Patel
+1.212.375.2694
tpatel@tiberend.com

Media Contact:
Ingrid Mezo
+1.646.604.5150
imezo@tiberend.com

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/stemonixs-microbrain-and-microheart-platforms-to-be-featured-in-podium-presentation-at-the-predict-4th-annual-3d-tissue-models-summit-300910056.html

SOURCE StemoniX

Contact:
Company Name: StemoniX, PREDiCT: 4th Annual 3D Tissue Models Summit
Web: http://StemoniX.com




Review Article Be the first to review this article
Aldec


Featured Video
Latest Blog Posts
Anupam BakshiAgnisys Automation Review
by Anupam Bakshi
Functional Safety and Security in Embedded Systems
Bob Smith, Executive DirectorBridging the Frontier
by Bob Smith, Executive Director
Phil Kaufman Award Goes on Hiatus for 2020
Colin WallsEmbedded Software
by Colin Walls
Why develop embedded software bottom up?
Jobs
ASIC Design Integration Engineer for Apple Inc at Cupertino, California
IC Design Engineer - SoC Integration for Xilinx at San Jose, California
Senior Analog IC Design Engineer for Marvell Semiconductor at Santa Clara, California
ASIC Design Engineer, for Apple Inc at Cupertino, California
Senior Java Developer/Architect for EDA Careers at Varies, North Carolina
Test Engineer for Marvell Semiconductor at Santa Clara, California
Upcoming Events
Accellera Day India 2020 at Online Event India - Dec 2 - 3, 2020
RISC-V Summit 2020. at United States - Dec 7 - 10, 2020
SEMICON Japan 2020 Goes Virtual at Japan - Dec 11 - 18, 2020
IPC APEX EXPO 2021 at San Diego Convention Center san diego - Mar 6 - 11, 2021
TrueCircuits:



© 2020 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us, or visit our other sites:
AECCafe - Architectural Design and Engineering TechJobsCafe - Technical Jobs and Resumes GISCafe - Geographical Information Services  MCADCafe - Mechanical Design and Engineering ShareCG - Share Computer Graphic (CG) Animation, 3D Art and 3D Models
  Privacy PolicyAdvertise